Skip to main content
. 2025 Aug 4;17(8):e89335. doi: 10.7759/cureus.89335

Table 3. Overview of the results.

A paired t-test (two-tailed) was performed, and the results were considered statistically significant when p-values were ≤ 0.05.

Structure (organs at risk and remaining brain volume) Three-dimensional conventional radiotherapy (mean±standard deviation) Volumetric arc radiotherapy (mean±standard deviation) t score p-value
V5 (%) 47.88 (±19.09) 75.09 (±19.02) -7.19 0.008
V10 (%) 38.53 (±16.83) 64.46 (±19.53) -7.51 0.003
V20 (%) 32.75 (±16.54) 39.86 (±16.64) -2.58 0.017
V30 (%) 28.96 (±15.92) 22.11(±10.71) 2.51 0.02
V40 (%) 24.83 (±15.88) 10.45 (6.49) 4.54 0.216
V50 (%) 20.07 (±12.05) 3.95 (±3.25) 6.49 0.644
V60 (%) 4.65 (±4.66) 0.71 (±3.25) 3.6 0.002
Whole brain (mean dose, Gy) 27.6 (±9.12) 26.88 (±7.59) 0.55 0.588
Brain stem (maximum dose, Gy) 45.54 (±17.18) 44.99 (±15.16) 0.4 0.691
Optic nerve left (maximum dose, Gy) 25.00 (±22.11) 22.68 (±14.61) 0.66 0.551
Optic nerve right (maximum dose, Gy) 27.50 (±24.87) 25.57 (±18.24) 0.57 0.576
Optic chiasma (maximum dose, Gy) 33.87 (±22.84) 37.35 (±17.57) -1.27 0.217
Lens left (maximum dose, Gy) 3.92 (±2.97) 4.79 (±2.38) -1.25 0.224
Lens right (maximum dose, Gy) 3.62 (±2.97) 5.06 (±2.91) -2.64 0.003
Planning target volume V95 (%) 96.06 (±2.60) 98.22 (±1.41) -3.9 0.001
Homogeneity Index 1.06 (±0.03) 1.06 (±0.12) 0.09 0.93
Conformity Index 0.95 (±0.02) 0.98 (±0.01) -4.18 0.001